Cell Therapy Catapult Company Profile

16:49 EDT 25th March 2019 | BioPortfolio

The Cell Therapy Catapult is a centre of translational excellence for cell therapy and regenerative medicine. Its vision is for the UK to be a global leader in the development, delivery and commercialisation of cell therapy, making it a location for business start-up and growth. Based in London at Guy's Hospital, the centre takes products into early clinical trials, providing clinical, technical, manufacturing, regulatory, health economics and market access expertise. There is a focus on collaboration and lowering barriers to investment and funding, and operations have grown rapidly since inception. UK Trade & Investment has valued the global regenerative medicine industry at just over £500 million, and estimates that it will be generating revenues of over £5 billion by 2021. For more information go to

News Articles [3048 Associated News Articles listed on BioPortfolio]

Cell and Gene Therapy Catapult: What makes the UK one of the best places for research?

Keith Thompson, CEO to Cell and Gene Therapy Catapult, describes the government’s Catapult initiative, established by Innovate UK.

Cell and Gene Therapy Catapult addresses sector skills gap

The Cell and Gene Therapy (CGT) Catapult has launched the first Advanced Therapy Medicinal Products (ATMP) focused apprenticeship programme, developed in partnership with The Medicine Manufacturing In...

Cell and Gene Therapy Catapult enters into partnership with the Japanese Society for Regenerative Medicine

Memorandum of Understanding between CGT Catapult and JSRM further enhances the UK’s relationship with regenerative medicine centres in Japan and contributes to the advancement of cell and gene thera...

UK’s cell and gene therapy industry continues to strengthen

The UK’s cell and gene therapy industry has seen a 60% increase in manufacturing space in the last year, new research published by the Cell and Gene Therapy (CGT) Catapult has revealed.

Cell and Gene Therapy Catapult centre gets green light

The independent cell and gene therapy researcher and industry partner, working with Innovate UK, has been granted new licences to progress its biomedical research

UK gene and cell therapy manufacturing hub clears regulatory hurdle

The UK's regulator has granted new licences to a hub of biotech companies to allow them to continue manufacturing of groundbreaking gene and cell therapies at an innovative purpose-built centre. The ...

Cell and Gene Therapy Catapult and pHion Therapeutics announce licencing agreement for RALA technology

Collaboration could reduce the cost of cell and gene therapy production by developing a more efficient method of modifying cells for therapies

UK surge in cell and gene therapy trials

A surge in cell and gene therapy trials - an increase of 37% since 2017 - highlights the UK’s leading position as a developmental hub in the sector, says the Cell and Gene Therapy Catapult.

Drugs and Medications [0 Results]


PubMed Articles [6322 Associated PubMed Articles listed on BioPortfolio]

The Acceleration of CAR-T therapy in Non-Hodgkin Lymphoma.

Recent advances in diffuse large B-cell lymphomas have included both identification of high-risk subtypes characterized by multiply relapsed and/or refractory disease as well as novel treatment in the...

Chimeric antigen receptor T cell therapy and other therapeutics for malignancies: Combination and opportunity.

Chimeric antigen receptor T (CAR-T) cell therapy provides possibility for the treatment of malignancies since clinical trials have shown that CAR-T therapy has a significant anti-tumor effect. Althoug...

Stem cell therapy for treating osteonecrosis of the femoral head: From clinical applications to related basic research.

Osteonecrosis of the femoral head (ONFH) is a refractory disease that is associated with collapse of the femoral head, with a risk of hip arthroplasty in younger populations. Thus, there has been an i...

Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?

Immunotherapy has revolutionized therapy in both solid and liquid malignancies. The ability to cure acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) with an allogeneic hematopoietic st...

Towards Standardized Stem Cell Therapy in Type 2 Diabetes Mellitus: A Systematic Review.

Clinical Trials [9227 Associated Clinical Trials listed on BioPortfolio]

T Cell Receptor Based Therapy of Metastatic Colorectal Cancer

T Cell Receptor Based Therapy of Metastatic Colorectal Cancer With mRNA-engineered T Cells Targeting Transforming Growth Factor Beta Receptor Type II (TGFβII)

Music Therapy and Hematopoietic Stem Cell Transplant

The purpose of this randomized, controlled study is to determine the effects of pre-transplant music therapy on mood, distress, and physical functioning variables in patients undergoing He...

Ultra Low Dose 4 Gy Orbital Radiation for Definitive Therapy of Indolent B Cell Lymphoma

The goal of this clinical research study is to learn about the effectiveness of low dose radiation therapy in patients with low grade B cell lymphoma or mantle cell lymphoma involving the ...

Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation

The purpose of this study is to evaluate whether virus-specific T cell lines (VSTs) are safe and can effectively control three viruses (EBV, CMV, and adenovirus) in patients who have had a...

Long-term Follow-up of Patients Treated With Autologous T Cells Genetically Modified

The purpose of this study is to monitor all patients exposed to an existing AUTO CAR T cell therapy, as well as the Sponsor's future autologous T cell products for up to 15 years following...

Companies [1825 Associated Companies listed on BioPortfolio]

Cell Therapy Catapult

The Cell Therapy Catapult is a centre of translational excellence for cell therapy and regenerative medicine. Its vision is for the UK to be a global leader in the development, de...

Catapult Systems

Catapult Systems provides Microsoft IT consulting services in enterprise solutions, infrastructure and custom development. With offices in Austin, Dallas, Houston, San Antonio, Denver, Tampa and Washi...

Catapult Consultants, LLC

Based in Arlington, Virginia, Catapult Consultants specializes in delivering innovative analytic and security solutions for cybersecurity, financial management and healthca...

Precision Medicine Catapult

Established in April 2015, the Precision Medicine Catapult is the UK's new national innovation centre for precision medicine. Its aim is to make the UK the most attractive place i...

Cell Therapy Foundation

The Cell Therapy Foundation is a not-for-profit organization committed to advancing the treatment of disease using adult stem cells. Emerging as a leader in raising funds for adult stem cell researc...

More Information about "Cell Therapy Catapult" on BioPortfolio

We have published hundreds of Cell Therapy Catapult news stories on BioPortfolio along with dozens of Cell Therapy Catapult Clinical Trials and PubMed Articles about Cell Therapy Catapult for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cell Therapy Catapult Companies in our database. You can also find out about relevant Cell Therapy Catapult Drugs and Medications on this site too.

Quick Search


Relevant Topic

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Corporate Database Quicklinks

Searches Linking to this Company Record